Targeted Strategies for Today's Evolving Markets

MissionIR Blog

TrovaGene Inc. (TROV) Starts Presentation at the 2012 Aegis Healthcare Conference

TrovaGene is the developer of patented technology for the detection of transrenal DNA and RNA, short nucleic acid fragments, originating from normal and diseased cell death that cross the kidney barrier and can be detected in urine.  The company has U.S. and European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing. For more information visit the company’s Web site at: www.trovagene.com

Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Aegis Capital’s management is committed to providing the highest level of service to its clients. The firm realizes this goal by running an independent, conflict-free platform that is focused on enhancing the goals of clients by bringing unencumbered advice, which enables them to freely create a plan centered on each client. For more information on Aegis Capital, visit www.aegiscapcorp.com.

Let us hear your thoughts below:

This entry was posted in Aegis Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *